ReleaseWire Connect

The global rapid tests market generated $21,455 million in 2016, and is projected to reach $39,103 million by 2023, growing at a CAGR of 8.9% from 2017 to 2023. Rapid tests are diagnostic assays designed for use where preliminary screening tests need to be conducted. These tests are easy, quick, and provide specific results; hence, are used in settings with limited resources. Rapid tests are incorporated in diagnosis of different diseases and health conditions such as HIV, influenza, malaria, cancer, pregnancy & fertility, and others.

Peritoneal dialysis (PD) is a form of dialysis that uses the inner lining of abdomen to filter blood when the kidneys are not functioning effectively. This procedure drains waste and excess fluid from body by using peritoneal membrane; it can be performed manually or via automated systems.

Endometrial ablation is adopted to remove or destroy the endometrial lining of the uterus for the treatment of heavy menstrual bleeding. Women with heavy menstrual bleeding are prescribed medicines. However, endometrial ablation is performed in case medication fails. This procedure is not recommended for women who wish to conceive.

Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in diabetes management, owing to their associated several advantages over other glucose monitoring devices. Unlike conventional glucose monitors, these systems enable periodic monitoring of glucose levels, which is crucial for avoiding diabetic complications. In addition, CGMS technology has laid a roadmap to the most awaited, high-tech, closed-loop artificial/bionic pancreas. Therefore, development of novel and technologically advanced CGMS is the prime focus of glucose monitoring device manufacturing companies. It offers a wide range of applications for all age-cohorts, healthcare settings (diagnostic centers/clinics, hospital ICUs, and home healthcare), and geographies. Thus, CGMS market poses lucrative opportunity for both CGMS manufacturers and insulin pump manufacturers.

The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are composed of silicone, PVC, or vinyl or red rubber latex.

Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), and immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III.

Articular cartilage is a complex tissue, which is devoid of blood supply (avascular). It is composed of distinct cells called chondrocytes suspended in a collagenous matrix. The key function of this tissue is to smoothen bone movements, and absorbs shock along with providing cushioning to the joints.

Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period of time. The global holter ECG monitoring market was valued at $226.5 million in 2016 and is expected to reach $418.3 million by 2023, registering a CAGR of 9.1% from 2017 to 2023.

Research Beam has added a report, titled, "Automotive Artificial Intelligence Industry - Global Opportunity Analysis and Industry Forecast, 2017–2024." According to the report, the global automotive artificial intelligence industry is expected to register a considerable CAGR from 2017 to 2024. The report offers a comprehensive analysis of drivers & restraints, key segments, market players, and Porter's Five Forces. This analysis is helpful for leading players, new entrants, investors, and stakeholders to gain insights on various opportunities and adopt different strategies to acquire major market share across the world.

Research Beam added a report, "Autonomous Vehicle Market by Level of Automation (Level 3, Level 4, and Level 5), and Component (Hardware, Software, and Service), Application (Civil, Robo Taxi, Ride Hail, Ride Share, Self-driving Truck, and Self-Driving Bus) - Global Opportunity Analysis and Industry Forecast, 2019-2026". The study provides a bird's eye view of the entire market. It covers the key benefits for stakeholders and the research methods used to gather the information. The report also includes an executive summary of the market, market overview, market segmentation, market drivers and restraints, market trends, market forecast, and the company profiles.